Regulatory News
Tuesday, May 17, 2016
AstraZeneca boosted by good results for biotech asthma drug
LONDON, May 17 (Reuters) - AstraZeneca's drive to
rebuild its portfolio of new medicines received a boost on
Tuesday with positive results for a biotech drug for severe
asthma that the company has...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment